The AhR antagonist StemRegenin 1 essentially abrogated the ameliorative effect of 5HIAA on colitis, as reflected by body weight, DAI, colon length, serum levels of IL‐22 and IL‐10, and colon histology (Figure 5C–H). Here, IL22 is linked to colitis.